CF
ACER

Copperwynd Financial’s Acer Therapeutics Inc ACER Stock Holding History

Copperwynd Financial’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-46,510
Closed -$65K – 145
2022
Q3 		$65K Buy
46,510
+23,255
+100% +$33.7K 0.04% 118
2022
Q2 		$29K Buy
+23,255
New +$48.7K 0.02% 118

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Copperwynd Financial's ACER Position: Q4 2022 in Review

Copperwynd Financial sold out of Acer Therapeutics Inc (ACER) in Q4 2022, closing a stake of 46,510 shares — an estimated $65K sold.

Copperwynd Financial first reported a position in ACER in Q2 2022 and held it in 2 quarters. The position peaked at $65K in Q3 2022. 32 funds tracked by Wall St. Rank hold ACER as of Q4 2022.

  • Copperwynd Financial reported no remaining Acer Therapeutics Inc position as of Q4 2022 after selling out during the quarter.
  • Copperwynd Financial sold 46,510 Acer Therapeutics Inc shares in Q4 2022, an estimated $65K.
  • Copperwynd Financial first reported a position in Acer Therapeutics Inc in Q2 2022 and held it in 2 quarters.
  • Copperwynd Financial's Acer Therapeutics Inc position peaked at $65K in Q3 2022.
  • 32 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2022.

Based on Copperwynd Financial's 13F filing for Q4 2022, filed 2 Feb 2023.